Introduction
Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are the major subtypes of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Approximately 80% of patients with GPA and 90% with MPA develop kidney involvement during the disease course. [1] ANCA-associated glomerulonephritis (AAGN) progresses to end-stage renal failure (ESRF) in approximately 20-40% of patients. [2] [3] [4] [5] The gold standard for establishing AAGN is a renal biopsy, which typically shows a pauci-immune necrotizing crescentic glomerulonephritis, [6, 7] which can be grouped into four classes. [8] Relapse in ANCA-associated vasculitis has been studied previously, but there are few studies on renal relapse in particular. It is important to find a balance between the risk of relapse and the risk of treatment-related adverse effects.
Identifying patients at high risk of renal relapse may aid in optimizing clinical management. Previous relevant studies mainly focused on relapse in general with clinical data, [2, 5, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] identifying proteinase 3 (PR3)-ANCA, GPA, lung or cardiovascular involvement, and better renal function at presentation as associated with relapse in general. [2, [10] [11] [12] [13] [14] 16, 17, 19] Note that different statistical analyses were used in these reports to determine the influence of various parameters on relapse; some published studies employed Fine & Gray's regression model while others used the standard Cox regression model. Both models are correct but address different research questions.
If more than one endpoint can occur, a competing risk analysis must be performed. In the case of renal relapse, ESRF and death are competing events, because the occurrence of one of them preclude the occurrence of renal relapse. Fine & Gray's regression model is used to estimate the effect of a risk factor on the cumulative incidence of renal relapse (CIR), which denotes the probability of experiencing renal relapse before time t. The classical Cox regression model is used to investigate the effect of risk factors on the rate of renal relapse. The parameters in the Cox regression model are hazard ratios and the interpretation is the traditional one. Note that relationships between risk factors (or explanatory parameters) and cause-specific hazards do not lead to simple relationships between explanatory variables and cumulative incidence. It is important to emphasize that both approaches are valid but that they answer different research questions and may render different results. Thus the effect of a parameter on the CIR might be different from its effect on the rate of renal relapse. Estimation based on Fine & Gray's model is useful for making predictions from the start of the disease, whereas the rate looks at parameters that increase the instantaneous risk of renal relapse and is useful for instant clinical decisions. In the present study, we apply both methods and discuss implications from their results.
We investigated whether diagnostic clinical and histological parameters are associated with renal relapse in patients with AAV with primary renal involvement. The study aim was to identify diagnostic tools that may be helpful in monitoring and managing patients with AAV, in particular in relation to renal relapse.
Material and Methods Patients
Patients included in this study were newly diagnosed with AAV with either mild to moderate or severe renal involvement (serum creatinine or > 500 μmol/L ( or > 5.8 mg/dl)). Patients were derived from two international multicenter randomized clinical European Vasculitis Society (EUVAS) trials: MEPEX and CYCAZAREM. [11, 20] Inclusion criteria for both trials are described elsewhere. [11, 20] The diagnosis was based on a clinical presentation compatible with ANCA-associated vasculitis and substantiated by a positive ANCA serology and/ or histology.
The MEPEX and CYCAZAREM trial follow-up continued until 12 and 18 months after diagnosis, respectively. During the trials, patients received protocolized treatment regimens. [11, 20] After these follow-up periods, patients were treated according to their local physician's standards. Patients were included and followed-up in the period June 1, 1995 
Clinical and histological parameters
Candidate parameters for clinical predictors of renal relapse in this study were serum creatinine levels, age, sex, diagnosis (GPA or MPA), ANCA-antigen specificity (PR3-ANCA or myeloperoxidase (MPO)-ANCA), and receiving plasma exchange during induction therapy. Patients were subdivided into two groups of GPA and MPA based on the clinical criteria. Renal-limited vasculitis was regarded as a form of MPA.
Candidate parameters for histological predictors were determined from paraffin sections of renal biopsies. Stains used for evaluation were silver, periodic acid-Schiff, hematoxylin and eosin, and trichrome. Sections were reviewed by two of a panel of five participating pathologists (IMB, FF, LHN, RW, and/or JAB). Both pathologists, blinded to patient data and the other observer's results, scored the biopsies separately and according to a previously standardized protocol, which was proven to be comprehensive and reproducible when used for histologic analysis. [23] One of the histological parameters included in this previously standardized protocol is interstitial infiltrates. Interstitial infiltrates were scored according to the following categories:
• None: <10% of the unscarred parenchyma infiltrated.
• Mild: 10 to 25% of the unscarred parenchyma infiltrated.
• Quite dense: 26 to 50% of the unscarred parenchyma infiltrated.
• Very dense: >50% of the unscarred parenchyma infiltrated.
In this study, only biopsies with a minimum of seven whole glomeruli were analyzed for glomerular lesions and the histopathological classification system of AAGN. [8] During plenary meetings, the panel of five pathologists decided upon the final scores to achieve consensus for each biopsy.
Clinical outcomes
The clinical outcome parameter was first renal relapse. A renal relapse was defined as a rise in serum creatinine of >30% or a fall in estimated glomerular filtration rate >25% and/or new hematuria or proteinuria (all attributable to active vasculitis), as indicated by the Birmingham Vasculitis Activity Score. [24] [25] [26] Patients were followed up until the last visit or death.
Statistical analyses
In this study, more than one endpoint could occur, namely renal relapse, ESRF, or death. The event of interest was renal relapse, while ESRF and death were competing events. Two regression models used in the competing risks framework were estimated here: Fine & Gray's model and Cox model. To study the effect of risk factors on the CIR the former model is employed while the latter is used to study the effects of risk factors on the rate of renal relapse, i.e. the cause-specific hazard. For more details concerning the difference between the two models, see Andersen et al. and Koller et al. [27, 28] The technical aspects of competing risks were described previously by Putter et al. [29] Univariate analyses with both methods were performed on every clinical and histological parameter. These analyses were performed on all patients without ESRF at baseline (n = 149), except for glomerular lesions and the histopathological class of AAGN. In addition, we performed a χ2-test to see whether the percent of renal relapse differed significantly between the histopathological classes. Also a Pearson correlation test was performed to investigate whether the presence of interstitial infiltrate was correlated with interstitial fibrosis. All baseline parameters were included as fixed covariates.
Because of the number of parameters (13 in this study) and the relatively low number of events, inclusion of too many parameters carries the risk of "overfitting." [30] Therefore, predefined smaller sets of entry parameters were included in the multivariate analyses, as follows: based on the original publication of the histopathological classification system of AAGN [8] ; based on parameters described previously more than once as being associated with relapse; and based on only histological parameters.
We denoted hazard ratios estimated by employing Cox regression model as cause-specific hazard ratio (csHR) and the hazard ratios estimated by using Fine & Gray's regression model as Fine & Gray's HR (F&G HR). All hazard ratios are provided with 95% confidence intervals (CI). A P value of less than 0.05 was considered significant. Statistical analyses were performed in SPSS (version 20.0; SPSS Inc, Chicago, IL) and R 2-18 (http://cran.r-project.org). All analyses concerning competing risks were performed with the mstate library. [31, 32] 
Results

Patients
A total of 174 patients with newly diagnosed AAV and a renal biopsy at diagnosis were included in this study. Table 1 shows the baseline patient characteristics. The median followup time was 102 months (range: 38-136 months).
Renal relapse
Of the 174 patients, 25 could not experience a renal relapse because they had ESRF at baseline. Of the remaining 149 patients, 22 were chronic kidney disease (CKD) stage 1-2 and 127 were CKD stage 3-5. Of these 22 CKD stage 1-2 patients, 5 (22.7%) developed CKD stage 3-5 within 5 years of follow-up. None of these 5 had experienced a renal relapse. In total, 31 patients experienced a renal relapse during follow-up. The CIR at 5 years was 9.5% (95% CI: 4.8-14.3%). A total of 19 patients developed ESRF during follow-up without experiencing renal relapse, and 29 died without experiencing renal relapse and without developing ESRF during follow-up. All patients who died during the follow-up period had CKD stage ! 3 at baseline. Seventy patients had none of these events during follow-up (Figs 1 and 2) .
Of the 149 patients, 113 had adequate renal tissue samples (at least seven whole glomeruli in the renal biopsy) for classification purposes. Their diagnostic renal biopsies were classified as follows: 23 focal class (20.4%), 58 crescentic class (51.3%), 18 mixed class (15.9%), and 14 sclerotic class (12.4%) ( Table 2) . Of these 113 patients, 24 experienced a renal relapse during (Fig 3) .
Competing risks analyses
To investigate which parameters are associated with the CIR, Fine & Gray's regression model was used. The traditional Cox regression model was used to estimate the effect of the parameters on the rate of renal relapse. [27] Fine & Gray's regression model
The univariate analyses showed that age, interstitial infiltrates, and intra-epithelial infiltrates were associated with CIR (Table A in S1 File). Older age was associated with a lower risk for experiencing a renal relapse. Higher scores of interstitial infiltrates and intra-epithelial infiltrates, which are both signs of acute disease activity, were associated with a lower risk for renal relapse. The histopathological class and CKD stage were not significantly associated with the risk of renal relapse. Among all histological parameters, only interstitial infiltrates had a significant association on the risk of renal relapse (the CIR) in the multivariate analysis (Table 3) . Although there was a correlation between interstitial infiltrates and interstitial fibrosis, this correlation was relatively weak (r = 0.236, P = 0.004). Therefore, interstitial fibrosis was not predictive for renal relapse. Patients with mild infiltrates had a four times lower risk for renal relapse than patients Among all clinical parameters, only age, corrected for other parameters, was associated with patients experiencing a renal relapse (Table B in S1 File).
Cox regression model for renal relapse
Among all baseline parameters, only the histopathological class was a significant risk factor for renal relapse in the univariate analyses (Table C in S1 File). CKD stage was not associated with renal relapse. After correction for age, baseline serum creatinine, and plasma exchange therapy, the histopathological class remained the only statistical significant risk factor for experiencing a renal relapse (Table 4) . Focal and crescentic class biopsies were associated with a lower cause-specific hazard ratio compared to sclerotic class biopsies. Focal class had a 10.1 times lower rate than the sclerotic class (csHR: 0.10; 95% CI: 0.02-0.60; P = 0.01), and crescentic class had a 4.7 times lower rate than the sclerotic class (csHR: 0.21; 95% CI: 0.07-0.62; P = 0.004). Patient cohort (MEPEX or CYCAZAREM) did not affect these associations.
With the inclusion of histopathological class, baseline serum creatinine, ANCA type, and diagnosis, only the histopathological class was a significant risk factor for renal relapse (Table 5) . Again, focal and crescentic classes were associated with a lower rate compared to (13) 7 (12) 3 (17) 3 (21) >201 μmol/L 6 (26) 50 (86) 14 (78) sclerotic class. In this model, focal class had a 10.8 times lower rate than the sclerotic class (csHR: 0.09; 95% CI: 0.02-0.55; P = 0.009), and crescentic class had a 4.8 times lower hazard rate than the sclerotic class (csHR: 0.21; 95% CI: 0.07-0.64; P = 0.006). There was no effect of patient cohort on these associations.
Discussion
This study shows that the histopathological class of AAGN in the renal biopsy at diagnosis is a risk factor for renal relapse. More specifically, sclerotic class was associated with a higher rate of renal relapse during long-term follow-up. It is important to emphasize that the effect of sclerotic class on the risk of renal relapse, i.e. the cumulative incidence, estimated by the Fine & Gray's model is different from its effects on the rate, i.e. the cause-specific hazard, estimated by the Cox regression proportional hazard model. This is because the way in which risk factors (or explanatory variables) are associated with the cause-specific hazards may not coincide with the way these covariates are associated with the cumulative incidence. The sclerotic class in AAGN is defined by !50% globally sclerosed glomeruli, meaning that the majority of glomeruli are non-functioning and that the compensatory ability of the kidneys is relied on heavily. Therefore, in these patients, a renal relapse may become more readily apparent because the compensatory capacity of a sclerotic class kidney is reduced. Moreover, with fewer functioning glomeruli, these glomeruli may become more vulnerable to a second hit, i.e., a relapse. In patients with AAGN that is not in the sclerotic class, minor relapses may remain subclinical because of the relatively higher number of preserved glomeruli and their compensatory ability. Patients' treatments were not based on the histopathological classification. Therefore, the sclerotic class may provide a setting in which renal relapse may be more likely to be detected than in the setting of another histopathological class. To investigate the effect of risk factors on the risk of renal relapse, i.e. the cumulative incidence, we applied Fine & Gray's regression model. Results show that absence of interstitial inflammatory infiltrates is associated with the risk of renal relapse. Patients with these infiltrates had a lower risk for future renal relapse than patients without these inflammatory infiltrates. The association of interstitial infiltrates with renal relapse persisted when corrected for other histological parameters. Previous EUVAS studies focused on predictive clinical and serological parameters for relapse in general. Walsh et al. investigated clinical and serological parameters predictive for relapse in general in a European cohort consisting of 535 patients. In that study, PR3-ANCA, lower serum creatinine levels at presentation, cardiovascular involvement, and GPA were independently associated with an increased risk for relapse, whether in the kidney or any other organ. [19] Our study is based on the histopathological data of those patients from the previous study by Walsh et al. who had a renal biopsy with sufficient tissue for proper evaluation; thus, we could investigate which histological parameters are predictive for renal relapse. Our finding that the absence of interstitial infiltrates is predictive for renal relapse is in line with the finding by Walsh et al. that better renal function increases the risk for a relapse in general because absence of interstitial infiltrates also correlates with better renal function at the time of biopsy. [33, 34] Experiencing a renal relapse has a negative influence on renal outcome. [35] Therefore, clinicians should realize that renal relapses must be identified and treated and keep in mind that those patients with a relatively benign clinical course at onset in particular will be prone to developing a renal relapse.
This study shows a higher cumulative risk for ESRF or death compared to renal relapse as shown in Fig 2. These results may have been influenced by the inclusion of patient from the MEPEX trial which included patients with serum creatinine >500 μmol/L or immediate dialysis dependency. Nineteen patients (11%) had ESRF during follow-up without experiencing a (clinical) renal relapse. It is possible that these patients had subclinical renal relapses, but they were not detected clinically. Based on this knowledge, we emphasize the need for chronic kidney disease management and renal protective strategies.
Our study has a number of limitations. Because of the sample size and relatively low number of events, we were limited in the size of the predefined multivariate analyses. To avoid bias, all multivariate analyses were predefined before the start of this study. To use the best possible predefined analyses, we constructed them based on the literature regarding the histopathological classification system of AAGN. Unfortunately, repeat biopsies during the time of renal relapse were not performed because it is generally considered that the risk of taking a biopsy would not weight against the benefit of a histologically proven renal relapse, keeping in mind that these can be diagnosed with a high level of certainty on the basis of the clinical findings.
In conclusion, we used two regression models to identify possible relationships between clinical and histopathological parameters at time of diagnosis of AAV with the risk of renal relapse, i.e. the cumulative incidence, and the effect on the rate of renal relapse, i.e. the causespecific hazard. The effect of sclerotic class on the risk of renal relapse estimated by the Fine & Gray's regression model was different from its effects on the rate estimated by the Cox regression model. Most likely, the lack of compensatory function in the largely sclerosed kidneys gives rise to the identification of a relatively high number of renal relapses. A strong predictive parameter for renal relapse was the absence of interstitial infiltrates as determined with the Fine & Gray model. Combining these results with those of previous studies, it seems that the patient with AAV characterized by a relatively benign clinical setting at onset is prone to a renal relapse. In this study, renal relapses occurring in patients with sclerotic class AAGN and renal relapses occurring in patients without interstitial infiltrates were mutually exclusive, which may indicate that they are essentially other kinds of relapses. Further studies are called to look further into the characteristics of renal relapses in AAV, in particular to find out whether the histopathological data at disease onset could serve as a guideline for the management of renal relapses in AAV.
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